Chemical Compound
Lansoprazole Imp. B (EP); Lansoprazole USP Related Compound A; Lansoprazole USP RC A; 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H-benzimidazole; Lansoprazole Sulphone; Lansoprazole Related Compound A; Lansoprazole Impurity B
CAS Registry Number
131926-99-3
Primary record
Lansoprazole Imp. B (EP); Lansoprazole USP Related Compound A; Lansoprazole USP RC A; 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H-benzimidazole; Lansoprazole Sulphone; Lansoprazole Related Compound A; Lansoprazole Impurity B
- 库存
- 2,438 克
- 纯度
- 99.7 %
- CAS
- 131926-99-3
化合物标识与属性
- CAS
- 131926-99-3
- PubChem CID
- 10385385
- SMILES
- CC1=C(C=CN=C1CS(=O)(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
- Canonical SMILES
- Cc1c(OCC(F)(F)F)ccnc1CS(=O)(=O)c1nc2ccccc2[nH]1
名称与同义词
- Lansoprazole Sulfone
- 131926-99-3
- lansoprazole sulphone
- Lansoprazole sultone
- Lansoprazole-sulfone
- Lansoprazole Related Compound A
- Lansoprazole EP Impurity B
- LansoprazoleSulfone-d4
- RefChem:152310
- A62FAW18P1
- UNII-A62FAW18P1
- LANSOPRAZOLE IMPURITY B
- AG-1813
- SCHEMBL106666
- DTXSID80157268
- Discontinued See: L175026
- MFCD08063665
- TVMJMCGRSSSSDJ-UHFFFAOYSA-N
- orb1306737
- C16H14F3N3O3S
- CHEMBL4520193
- DTXCID1079759
- SCHEMBL30052062
- CTK6B3681
- AG 1813
- BCP17469
- 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfonyl)-1H-benzo[d]imidazole
- EX-A10727
- ZINC21981235
- AKOS015914410
- CS-O-10332
- CS-W009330
- HY-W008614
- IL32158
- CID10385385
- Lansoprazole sulfone - Bio-X trade mark
- AC-30440
- AS-74241
- BL300141
- DA-54788
- SY071651
- lansoprazole sulfone, 98% - 10mg 10mg
- J366.139C
- Lansoprazole EP Impurity B/USP Impurity A
- RT-013553
- FT-0670723
- LANSOPRAZOLE IMPURITY B [EP IMPURITY]
- NS00116523
- 1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfonyl)-
- F19472
- LANSOPRAZOLE RELATED COMPOUND A [USP-RS]
- 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-
- A899118
- Lansoprazole EP Impurity B (Lansoprazole Sulfone)
- A1-04640
- 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-1H-benzimidazole
- I14-41521
- LANSOPRAZOLE RELATED COMPOUND A [USP IMPURITY]
- Q27273677
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfonyl]-1H-benzimidazole
- 2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfonyl}-1H-1,3-benzodiazole
- B0064-302135
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfonyl]-1H-benzimidazole
- 1H-Benzimidazole,2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfonyl]-
- 1H-Benzoimidazole-2-yl[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl] sulfone
- 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methane)sulfonyl)-1H-1,3-benzodiazole
- 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfonyl)-1H-1,3-benzodiazole
- 2-[[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDYL]-METHYL]SULPHONYL]-BENZIMIDAZOLE
- 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfonyl]-1H-benzo[d]imidazole
- 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfonyl]-1H-benzoimidazole
- 2-[[4-(2,2,2-Trifluoroethoxy)-3-methylpyridine-2-yl]methylsulfonyl]-1H-benzoimidazole
- 2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylsulfonyl]-1H-benzimidazole
- 2-{[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfonyl}-1H-1,3-benzimidazole
- Lansoprazole Related Compound A, United States Pharmacopeia (USP) Reference Standard
- 1184999-77-6
- 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl} sulfonyl)-1h-1,3-benzimidazole
- 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H-benzimidazole (Lansoprazole Sulphone)
- Lansoprazole Imp. B (EP); Lansoprazole USP Related Compound A; Lansoprazole USP RC A; 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphonyl]-1H-benzimidazole; Lansoprazole Sulphone; Lansoprazole Related Compound A; Lansoprazole Impurity B